The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
AstraZeneca achieved positive Phase 3 trial results for its drug Imfinzi in treating liver cancer. The drug is expected to become a 'super-blockbuster' and a major growth driver for the company. The treatment targets cases where tumors cannot be surgically removed, a category with historically limited options.